Herbas VPB

Print
EN | LT
LT - IMMUNOGLOBULIN EXPRESSION LEVELS AS BIOMARKER FOR PROTEASOME INHIBITOR RESPONSE
EN - IMMUNOGLOBULIN EXPRESSION LEVELS AS BIOMARKER FOR PROTEASOME INHIBITOR RESPONSE

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 38/05
A61K 38/07
A61K 31/145
A61P 35/02
C12Q 1/68
G01N 33/574
European patent
(11) Number of the document 3030251
(13) Kind of document T
(96) European patent application number 14752766.7
Date of filing the European patent application 2014-08-08
(97) Date of publication of the European application 2016-06-15
(45) Date of publication and mention of the grant of the patent 2018-10-24
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2014/050333
Date 2014-08-08
PCT application publication
(87) Number WO 2015/021376
Date 2015-02-12
Priority applications
(30) Number Date Country code
201361863809 P 2013-08-08 US
201361875954 P 2013-09-10 US
201462005904 P 2014-05-30 US
Inventors
(72)
TUCH, Brian, US
DEGENHARDT, Jeremiah, US
LOEHR, Andrea, US
KWEI, Kevin, US
KIRK, Christopher, J., US
Grantee
(73) Onyx Therapeutics, Inc., One Amgen Center Drive, Thousand Oaks, CA 91320-1799, US
Title
(54) IMMUNOGLOBULIN EXPRESSION LEVELS AS BIOMARKER FOR PROTEASOME INHIBITOR RESPONSE
  IMMUNOGLOBULIN EXPRESSION LEVELS AS BIOMARKER FOR PROTEASOME INHIBITOR RESPONSE
Last update date 2021-04-30